When HS Follows the Hormonal Pattern
When flares reliably worsen before menstruation, intensify at certain life stages, or occur alongside PCOS and insulin resistance, the hormonal system is not incidental — it is central. Treating the skin while leaving the hormonal environment unchanged is why this form of HS keeps returning.
Why Hormones Drive This Form of HS
AyurvedaPitta-Meda Imbalance · Artava DushtiHS is always a systemic condition. But in hormonal HS, the hormonal system is not a secondary contributor — it is the primary amplifier. Understanding why requires looking at what androgens actually do inside the skin and how insulin resistance magnifies the process.
The Androgen Mechanism
Androgens — male sex hormones present in both men and women — directly stimulate the sebaceous glands attached to hair follicles. When androgen levels are elevated or when receptor sensitivity is heightened, these glands overproduce. The excess sebum, combined with abnormal keratin production, creates the follicular blockage that initiates HS lesions.
In women with PCOS, this androgen excess is not episodic — it is chronic. The follicular environment is in a state of continuous provocation, which is why lesions form repeatedly in the same locations and why hormonal fluctuations during the menstrual cycle create predictable flare windows.
This is distinct from HS driven primarily by structural or inflammatory factors. Here, the hormonal signal must be corrected — not bypassed — for the inflammatory cycle to slow meaningfully.
The Insulin Resistance Amplifier
Insulin resistance does not cause HS in isolation, but it creates a metabolic environment that makes hormonal HS significantly worse. Elevated insulin stimulates the ovaries and adrenal glands to produce more androgens, compounding the androgen excess that drives follicular dysfunction.
This is why women with PCOS and insulin resistance often have more frequent and more severe HS flares than those with androgen imbalance alone. The two systems reinforce each other: high androgens worsen insulin sensitivity, and insulin resistance increases androgen production.
Breaking this loop requires addressing both sides — the hormonal regulation and the metabolic function — rather than managing either in isolation.
Androgen Excess
Elevated DHT and testosterone levels — whether from PCOS, adrenal dysfunction, or receptor hypersensitivity — continuously stimulate follicular glands. This creates the structural conditions for repeated blockage and inflammation regardless of external triggers.
Cyclical Progesterone Shifts
In the luteal phase — the week before menstruation — progesterone levels rise and then fall sharply. This shift increases sebum production and alters immune tolerance in the follicular unit, creating a predictable window of heightened HS activity that correlates directly with the cycle.
Insulin Resistance
Elevated fasting insulin signals the body to produce more androgens centrally. This metabolic loop — insulin resistance driving androgen production, androgens worsening insulin sensitivity — means that dietary and metabolic factors are not lifestyle choices but therapeutic targets in hormonal HS.
Adrenal Dysregulation
Chronic stress activates adrenal androgen production independently of ovarian function. In patients with high cortisol burden — whether from psychological stress, sleep disruption, or metabolic pressure — adrenal androgens add a further layer to the hormonal load that sustains HS activity.
How the Menstrual Cycle Maps to HS Flares
When a patient reports that flares are predictably worse in the days before menstruation, this is not coincidence. It is the follicular environment responding to the hormonal fluctuations of the luteal phase. Understanding this rhythm is clinically significant — it identifies the hormonal driver as dominant and guides what the treatment must address.
Inflammation subsides. Lesion activity typically decreases as hormonal levels reset.
HS Activity: LowerOestrogen rises, androgens relatively balanced. Many patients report their clearest skin during this window.
HS Activity: LowestLH surge can briefly elevate androgens. Some patients notice early follicular sensitivity beginning.
HS Activity: RisingProgesterone peaks then drops. Sebum production increases. Immune tolerance in follicular tissue falls. Peak HS activity window.
HS Activity: Highest"When flares consistently worsen in the week before menstruation, the hormonal driver is not incidental — it is dominant. Any treatment plan that does not address hormonal regulation will produce results that are temporary at best."
The Internal Chain in Hormonal HS
Hormonal HS develops through an interconnected sequence. Each stage compounds the next — which is why addressing only one part of the chain produces limited and temporary relief.
Androgen Excess Stimulates Follicular Glands
Elevated androgens — from PCOS, insulin resistance, adrenal overactivity, or receptor hypersensitivity — continuously stimulate the sebaceous glands attached to hair follicles. The glands overproduce sebum beyond what the follicular canal can clear, creating the conditions for progressive blockage.
Follicular Occlusion Builds
Sebum accumulation combines with abnormal keratin desquamation inside the follicular unit. The canal narrows and eventually obstructs. In friction-prone areas — groin, axilla, inframammary folds — physical pressure compounds the blockage. The follicle becomes a sealed environment under increasing internal pressure.
Rupture Triggers Immune Cascade
When the blocked follicle ruptures — often triggered by the hormonal shifts of the luteal phase — its contents release into surrounding dermis. The immune system reads this as a significant threat and responds with intense local inflammation. This produces the painful nodules and abscesses characteristic of HS. In women with PCOS, this immune response is often amplified by systemic low-grade inflammation already present in the metabolic environment.
Incomplete Resolution — Chronic Recurrence
When the lesion partially resolves, the hormonal environment — still unchanged — begins stimulating the same follicular units again. Each cycle leaves behind minor structural changes: fibrosis, altered tissue architecture, compromised lymphatic drainage. Over months and years, these changes accumulate into the scarring, tunnelling, and chronic drainage that define advanced hormonal HS.
Systemic Inflammation Entrenches the Pattern
As HS becomes established, the inflammatory load it generates feeds back into the metabolic environment — worsening insulin resistance, disrupting cortisol regulation, and further destabilising hormonal balance. The condition begins to sustain its own internal drivers. This is the point at which surface-level interventions become progressively less effective, because the disease has developed internal momentum beyond its original hormonal trigger.
When the Pattern Keeps Repeating
In hormonal HS, recurrence is not random. It follows the hormonal cycle, responds to hormonal life events, and worsens as the underlying metabolic environment deteriorates. Each recurrence is information — it tells you that the hormonal root cause has not been corrected.
A significant proportion of women with HS report predictable pre-menstrual worsening — a clear indicator that hormonal regulation is the primary therapeutic target.
Women with PCOS are significantly more likely to develop HS. The androgen excess and insulin resistance that define PCOS create the internal environment that sustains HS activity.
Most patients receive surface-level treatment for years before the hormonal pattern is identified and addressed — during which time the disease progresses structurally.
"If HS keeps coming back, it means the root cause has not been addressed. In hormonal HS, that root cause is the hormonal environment itself — and it requires correction, not suppression."
The Progression Pattern in Hormonal HS
Hormonal HS tends to follow a recognisable trajectory. The speed of progression depends largely on whether internal drivers are addressed — or whether treatment remains focused on the lesions themselves.
Cyclical Nodules
Individual painful nodules appear and resolve in rhythm with the menstrual cycle. Lesions are typically singular, in one or two locations. This stage is often misattributed to ingrown hairs or hormonal acne, delaying accurate identification and appropriate intervention.
Multiple Sites, Persistent Inflammation
Lesions spread to multiple hormonal areas — groin, axilla, inframammary regions. Recurrence becomes more frequent and less correlated with cycle timing alone. Early sinus formation may appear. The hormonal driver is now compounded by established local inflammation and structural tissue changes from repeated lesion cycles.
Chronic Tunnelling, Systemic Burden
Sinus tracts connect multiple lesion sites. Continuous or near-continuous discharge develops. The inflammatory load affects systemic metabolic function — worsening insulin resistance and creating a feedback loop that sustains androgen excess. At this stage, the condition has internal momentum beyond its hormonal origin alone.
What Treating Hormonal HS Actually Requires
Hormonal HS cannot be meaningfully managed through skin-directed treatment alone. The hormonal and metabolic environment must be corrected — systematically, in phases — for lesion activity to reduce and stay reduced. Each phase of the EPOH Protocol addresses a specific layer of the condition.
Why first
In hormonal HS, systemic inflammation is both a driver and a consequence. Before the hormonal system can be effectively corrected, the inflammatory and metabolic load must be reduced. This creates the internal conditions in which subsequent hormonal regulation can take effect. Without this foundation, hormonal interventions produce limited and inconsistent results.
This phase addresses gut-derived inflammatory signals, metabolic toxin load, and the systemic inflammatory state — all of which interact with androgen production and insulin sensitivity.
The central target
This phase directly addresses androgen excess and the hormonal mechanisms that sustain follicular overstimulation. The approach is not to suppress hormonal function broadly — it is to restore the regulatory balance between androgen production, androgen clearance, and receptor sensitivity.
Where PCOS is present, ovarian hormonal signalling is addressed specifically. Where adrenal androgens are elevated — often from chronic stress — adrenal regulation is addressed as a separate but related component. Each patient's hormonal profile shapes the specific focus of this phase.
Breaking the metabolic loop
Insulin resistance amplifies androgen production and sustains the internal environment that drives hormonal HS. This phase works to improve cellular insulin signalling — reducing the central stimulus for ovarian and adrenal androgen production and interrupting the feedback loop between metabolic dysfunction and hormonal imbalance.
This requires internal formulations designed to improve metabolic function, alongside dietary and lifestyle adjustments that are specific to the patient's metabolic state rather than generic recommendations.
Repairing accumulated damage
As the hormonal and metabolic environment stabilises, treatment shifts to repairing the structural damage from repeated lesion cycles — fibrosis, sinus tract formation, impaired lymphatic drainage, and compromised skin integrity in affected areas. This phase supports the tissue repair processes that cannot occur efficiently while active inflammation continues.
Sustaining the corrected state
Hormonal HS is a condition with strong recurrence tendencies if the underlying hormonal and metabolic environment is not maintained in a corrected state. This phase focuses on regulatory resilience — building the body's capacity to maintain hormonal balance through normal hormonal fluctuations, stress exposure, and life events without returning to the pattern of active HS.
Herbal Formulations Designed for Hormonal HS
The formulations used in hormonal HS are structured around the specific drivers of this subtype — androgen regulation, insulin sensitivity, inflammatory load, and tissue healing. They are built individually, based on each patient's hormone profile, metabolic state, and disease stage.
Androgen Regulation Formula
Specifically formulated to modulate androgen activity at both production and receptor level. This targets the central driver of follicular overstimulation — reducing the hormonal signal that initiates the inflammatory cycle without broadly suppressing endocrine function. The composition is adjusted based on whether the androgen excess is primarily ovarian, adrenal, or receptor-mediated.
Insulin Sensitivity Support Blend
A metabolically targeted formulation designed to improve cellular insulin responsiveness and reduce fasting insulin levels. By addressing insulin resistance directly, this formula interrupts the metabolic amplification of androgen production — breaking the feedback loop that sustains hormonal HS activity in patients with PCOS and metabolic syndrome.
Gut and Inflammatory Load Formula
Addresses the gut-derived inflammatory signals and toxin accumulation that sustain systemic inflammation and worsen hormonal dysregulation. In hormonal HS, gut health and hormonal health are interconnected — impaired gut function affects oestrogen and androgen metabolism. This formula supports both inflammatory reduction and hormonal clearance through improved gut function.
Blood and Tissue Purification Blend
A deep-acting formula that works to reduce the circulating inflammatory mediators that sustain lesion activity and impair healing. Supports lymphatic drainage in the affected regions — improving the clearance of inflammatory debris that otherwise prolongs the resolution phase and contributes to sinus tract formation.
Tissue Repair and Skin Integrity Formula
Supports the regeneration of skin and subcutaneous tissue in areas where repeated inflammation has caused fibrosis, structural disruption, and impaired healing. Also promotes follicular normalisation — reducing the structural vulnerability of the follicular units that have been repeatedly damaged by the HS cycle.
Adrenal and Stress Regulation Blend
A targeted support formula for patients where adrenal androgen excess — driven by chronic stress, cortisol dysregulation, or adrenal hypersensitivity — is a significant contributor. Supports the adrenal-hypothalamic axis to reduce stress-driven androgen production without suppressing the normal stress response the body requires.
Formulations are never prescribed generically. Each patient's hormone profile, insulin status, gut function, disease stage, and response pattern determines the precise composition used. No herb names are listed here — not because the information is withheld, but because the same therapeutic function can be achieved through different combinations depending on individual constitution and state. What matters is that the function is correctly targeted for each patient.
What Supports Hormonal Correction
In hormonal HS, lifestyle factors are not peripheral. Diet, sleep, stress management, and movement all directly influence insulin sensitivity, androgen production, and systemic inflammation — the same systems the internal formulations are targeting. Lifestyle alignment amplifies the therapeutic effect significantly.
Dietary Approach for Insulin and Androgen Balance
A low-glycaemic approach that reduces the post-meal insulin spikes that drive androgen overproduction is a structural component of hormonal HS management — not an optional addition. This does not mean extreme restriction, but a calibrated pattern of eating that keeps insulin within a range that does not amplify androgen signalling. Specific dietary guidance is individualised based on metabolic status.
Sleep and Hormonal Regulation
Sleep is the primary regulatory window for cortisol and several sex hormones. Disrupted or inadequate sleep elevates cortisol and adrenal androgen production — creating or worsening the hormonal environment that drives HS. Restoring consistent sleep architecture is not a wellness consideration in this context; it is a direct therapeutic target.
Exercise and Insulin Sensitivity
Regular, appropriately-paced physical movement is one of the most reliable methods for improving cellular insulin sensitivity. In hormonal HS, this directly reduces the metabolic signal that drives androgen overproduction. The type and intensity of exercise matters — intense exercise that elevates cortisol significantly can briefly worsen adrenal androgen production. Guidance is paced to the individual's current metabolic state.
Stress Load and Adrenal Androgens
Chronic psychological or physiological stress sustains adrenal androgen production at levels that compound ovarian androgen excess in women with PCOS. Stress regulation is therefore not a supportive measure — it is a component of hormonal correction. Approaches that reduce cortisol burden consistently are integrated into the treatment programme alongside internal formulations.
HS Presents in Different Patterns
Hormonal HS frequently overlaps with other subtypes. Understanding how the same internal drivers express differently by location and structure helps clarify the full picture of an individual patient's condition.
The Hormonal Pattern Can Be Understood and Addressed
If your HS follows a cyclical pattern, is linked to PCOS or insulin resistance, or has continued to recur despite treatment — the hormonal root cause has not been addressed. A structured evaluation identifies the specific hormonal and metabolic drivers active in your case and forms the basis of a personalised treatment plan.